ABSTRACT -Objective: To call attention to an unusual complication of decompressive haemicraniectomy in the treatment of malignant haemispheric infarction. Method: We describe a case in which partial decompression occurred despite large craniectomy. Complete decompression followed resection of the temporal muscle. Pertinent literature is briefly reviewed. Case description: A 55-year old woman developed massive right middle cerebral artery infarction evolving to cerebral haerniation in 40 hours. Decompressive haemicraniectomy without cortical excision was unable to revert coma and decerebrate posturing because of a massive temporal muscle haemorrhage with persistent contralateral deviation of midline structures. Muscle resection was followed by adequate external haerniation of the affected haemisphere and fast recovery. Cranioplasty was succesfully performed 22 days later, following gradual regression of cerebral oedema. Conclusion: There is an increasing perception of the need to operate patients with massive middle cerebral or internal carotid artery territory infarctions before the development of coma and cerebral haerniation. The most common factor leading to inadequate surgical decompression is small size craniectomy. The case reported calls attention to temporal muscle bleeding as an additional complication of craniectomy.
Decompressive hemicraniectomy is being increasingly performed all over the world in an attempt to save the life of patients with intracranial hypertension and internal cerebral herniation associated with complete middle cerebral artery (MCA) or internal carotid artery (ICA) infarction. We describe a case in which a surgical complicationbleeding of the temporal muscle -precluded efficient decompression from the procedure and led to persisting coma and haerniation.
CASE
A 55-year old woman with acute cerebral infarction was admitted 12 hours after the onset of a massive MCA infarct (Fig 1a) . Cardiovascular risk factors included type II diabetes mellitus, systemic arterial hypertension and current smoking. The patient had already suffered a myocardial infarction and been subjected to coronary bypass surgery 10 years before. At admission, she was alert and exhibited mild confusion, complete left haemiplegia and haemianestesia and difficulty moving her eyes leftwards. Despite conventional management including vital sign monitoring, oxigen supplementation, subcutaneous low molecular weight heparin (enoxaparine) 40 mg/day, intravenous hydration with isotonic saline solution and fixed doses of mannitol (1.2 g/Kg/day), the patient developed coma and signs of uncal haerniation with respiratory insufficiency 24 hours later. Controlled hyperventilation and emergency treatment with hypertonic saline were followed by decompressive haemicraniectomy performed 4 hours after deterioration. A large (14 cm diametre) bone flap was removed (Fig 1b) with no cerebral tissue resected.
The patient, however, was still comatose and exhibited bilateral decerebrate reaction to painful stimuli 48 hours after surgery. A magnetic resonance exam of the brain (MR) disclosed persistent mass effect with marked deviation of anterior midline structures related to a large epidural mass thought to represent a temporal muscle haemorrhagic suffusion (fig 2) . After resection of the temporal muscle ( fig  3) , the patient awakened, was extubated and had a subsequent uneventful clinical course with progressive partial recovery (feeding and walking independently but still with severe arm paresis and haemianopia 6 months later). The bone flap was reimplanted 22 days later.
DISCUSSION
Clinically significant cerebral oedema develops after at least 10% of large MCA infarcts, probably more frequently in ICA infarcts. Mortality among those in which this progresses to the point of cerebral haerniation -the so called malignant MCA infarcton -reaches 80% 1 . A number of current approachs to treat this complication are of dubious value. These include widely used drugs such as mannitol or barbiturates [2] [3] [4] . Vigorous sustained mechanical hyperventilation may even be harmful in similar contexts of uncontrolled intracranial hypertension 5 . Hypother)mia is being actively investigated in the treatment of massive brain infarction and is possibly associated with delayed evolution of infarction 6, 7 . It is at least doubtfull however that it could reduce definite infarction size or improve neurological outcome. Hypothermia is probably less effective than decompressive craniectomy, but it may have an addictive role to surgery 8 . Although feasible, blanket cooling is associated with a number of severe complications including bleeding diathesis, arritmias and cardiac failure and uncontrolled intracranial hypertension during rewarming 7 . Alternative methods for minimally invasive endovascular cooling in acute stroke are being investigated 9 , but the associated risks are not negligible and their clinical role is still undefined.
The technique for decompressive haemicraniectomy is already well established 10, 11 . It includes the A B remotion of a large (≥ 12 cm) bone flap with a circular or oval shape including the frontal, parietal, temporal and parts of the occipital squamae (with special care to avoid producing sharp bone edges); fixation of the dura at the edge of the craniectomy to prevent epidural bleeding; opening of the dura (usually one longitudinal and three radial incisions almost reaching the osseous rim) and placement of a dural patch made of lyophilised cadaver dura or more recently microporic poliester-uretane (Neuro-Patch ® )
in the incision. The lenght (15 to 20 cm) and width (2.5 to 3.5 cm) of the patch are somewhat variable. Extensive beveling is avoided as it may lead to profuse venous bleeding. Also, the midline should be spared by 1 cm because opening of bridging veins also promotes bleeding. The bone flap is inserted in the abdominal wall and reimplanted between 3 and 12 weeks later (alternatively an artificial flap may be made at that time).
In a recent retrospective study of 60 operated patients, Wagner and coleagues 12 found a surprising 70% incidence of ischaemic (28.4%) or haemorrhagic lesions (41.6%) directly related to haemicraniectomy. Most lesions were small and probably of no major clinical impact. Small epidural or subgaleal haemorrhages occurred in 10% of all patients, and small subdural haematomas in 5%. Only one patient developed a large epidural haematoma needing reoperation. The authors found a statistically significant inverse correlation between the frequency of parenchimal bleeding caused by craniectomy (but not of ischaemic lesions or epidural bleeding) and the size of the bone defect. Also, sharp bone edges were associated with haemicraniectomy-related lesions of any type. Most importantly, patients with haemicraniectomy-associated parenchimal haemorrhages (but not those with other lesions) exhibited a higher mortality rate -45% compared with 20% in patients without haemorrhages. 
A B
Craniectomy-associated parenchimal bleeding and ischaemic lesions are probably due to mushroom-like haerniation associated with an increase in shear forces acting and distorting the brain. Epidural haemorrhages are probably caused by the wound surface. We alert here to haemorrhagic suffusion of the temporal muscle leading to inadequate decompression and persisting harm to the herniating brain. We speculate that this bleeding complication may be more common in acute stroke patients receiveing platelet antiaggregants and anticoagulants in the pre-operative phase. In these patients, consideration should be given to the exeresis of large temporal muscles with haemorrhagic suffusion.
The importance of the early indication of haemicraniectomy in patients with massive MCA infarcts has been emphasised. In an open study 11 of 63 patients with complete MCA territoy strokes -with or without additional anterior or posterior artery territory infarction -those operated early (mean time from onset 21 hours, range 8 to 42 hours), had a 16%mortality rate. Only 4 of these 31 patients had signs of uncal haerniation with a unilaterally fixed and dilated pupil. The results compared favourably with those attained in patients previously studied by the same group and operated later (mean 39 hours, range 6 to 112 hours), who exhibited a 34.4% mortality rate 13 . Also, functional evolution (Barthel index and Rankin scale) was better and lenght of stay in the intensive care unit was shorter in the earlyoperation group.
We are now partially able to predict the patients with maximum risk of developing haerniation from MCA infarctions. Many authors emphasised the predictive role of large hypodensities as seen in admission CT exam. Total or large (> 50%) hypodensities in the MCA territory are associated with a 85% death risk 14 . The sensitivity for prediction of the syndrome seems somewhat low, however.
A number of published reports tried to find out important clinical predictors of fatal brain swelling. Nausea/vomiting was suggested as an important marker in one model 15 but not in other 16 . Kasner and cols 16 reviewed clinical and radiological criteria in 201 patients with extensive MCA infarctions, 94 (47%) of which died from cerebral oedema. A number of factors independently increased the risk of developing fatal cerebral oedema (Table) . Risk was correlated with increasing numbers of factors present, being greater than 85% in patients with 4 or 5 factors. The model is not perfect and also has a relatively low sensitivity but is able to predict 70% of the fatal events related to cerebral oedema.
The role of routine monitoring of intracranial pressure and a number of other parameters in guiding surgical indication in patients initially treated conservatively is still a matter of debate. Costs and the possible delay of urgent surgery must be wheighed against the importance of the obtained information, especially avoidance of unneccessary interventions and adequate identification of the patients who could most profit from surgery. Although haerniation is usually associated with increasing intracranial pressure, the degree of displacement of brainstem structures may be greater than its increase as measured by a peripheraly located parenchymal device 17 . Isolated intracranial pressure monitoring is not an adequate standard in monitoring of antioedema treatment 18 , which should also include measurements of cerebral perfusion pressure, oxigen consumption (jugular bulb venous oxigen saturation) and osmolality.
